نتایج جستجو برای: xpert mtbrif assay

تعداد نتایج: 222590  

Journal: :Bulletin of the World Health Organization 2014
Betina Durovni Valeria Saraceni Marcelo Cordeiro-Santos Solange Cavalcante Elizabeth Soares Cristina Lourenço Alexandre Menezes Susan van den Hof Frank Cobelens Anete Trajman

PROBLEM The World Health Organization has endorsed the Xpert MTB/RIF (Xpert), an automated polymerase-chain-reaction-based assay, for the rapid diagnosis of tuberculosis. However, large-scale use of a new technology calls for preparation and adaptation. APPROACH A pilot implementation study was conducted in two Brazilian cities to explore the replacement of sputum smear microscopy with Xpert....

2018
Xiaofu Pan Shoufeng Yang Margaret A. Deighton Yue Qu Liang Hong Feifei Su

Introduction: The Xpert MTB/RIF is recommended by the World Health Organization as a first line rapid test for the diagnosis of pulmonary tuberculosis (TB); however, China does not routinely use this test, partially due to the lack of a sufficient number of systematic evaluations of this assay in local patients. The aims of this study were to comprehensively assess the diagnostic performance of...

Journal: :Journal of clinical microbiology 2012
M Barnard N C Gey van Pittius P D van Helden M Bosman G Coetzee R M Warren

Molecular diagnostics for Mycobacterium tuberculosis have recently been endorsed by the World Health Organization. The Xpert MTB/RIF assay was endorsed for use on patient material, regardless of smear gradation, while the GenoType MTBDRplus (version 1) has been limited for use on smear-positive patient material. In this study, we evaluated the diagnostic performance of the Xpert MTB/RIF and Gen...

Journal: :Journal of clinical microbiology 2009
Haihui Huang Andrej Weintraub Hong Fang Carl Erik Nord

A commercial multiplex real-time PCR assay (Cepheid Xpert C. difficile assay) for the diagnosis of Clostridium difficile infection was evaluated. The sensitivity and specificity of the Cepheid assay were 97.1% and 93.0% for fresh stools, using the cell cytotoxicity neutralization assay as the reference. Using PCR ribotyping as the reference for ribotype 027 strains, the corresponding figures we...

Journal: :BMC Infectious Diseases 2021

Abstract Purpose With over 50 SARS-CoV-2 gene amplification assays that have been EUA cleared with minimal experimental validation performed, it is likely not all of these are comparable in their ability to detect clinical specimens. Thermo Fisher Scientific a relatively new company the molecular diagnostics field and purpose this study was compare performance TaqPath™ Combo Kit an established ...

2017
Raghuprakash Reddy Gerardo Alvarez-Uria

The Xpert MTB/RIF assay can detect mutations in rpoB gene that confer rifampicin resistance (RR) using five overlapping probes (A, B, C, D, and E). In this study, we described our experience with the Xpert assay in a rural setting in India. During the study period, 3250 samples were processed. The result was unsuccessful in 5.7% of cases. For extrapulmonary specimens, the risk of unsuccessful r...

Journal: :Journal of clinical microbiology 2015
Nila J Dharan Danielle Amisano Gerald Mboowa Willy Ssengooba Robert Blakemore Rachel W Kubiak Derek T Armstrong Martin Jones Yukari C Manabe Moses L Joloba Jerrold J Ellner Susan E Dorman David Alland

The Xpert MTB/RIF (Xpert) assay permits rapid near-patient detection of Mycobacterium tuberculosis in sputum; however, the test sensitivity remains suboptimal in paucibacillary specimens that are negative for acid-fast bacilli using smear microscopy. Xpert testing includes dilution with sample reagent, and when processed sputum pellets are tested, the recommended sample reagent/pellet ratio is ...

Journal: :Revista espanola de salud publica 2013
María Ángeles Asencio Egea María Huertas Vaquero Rafael Carranza González Jesús Castellanos Monedero María Franco Huerta José Manuel Bravo Nieto José María Tenías Burillo

BACKGROUND Tuberculosis (TB) remains an important public health problem worldwide. Our objective was to estimate the economic and health care impact of the introduction of an early diagnosis tecnique of TB, the Xpert MTB/RIF® assay (Xpert). METHODS The savings was estimated on the basis of reduction in the time of TB hospitalization at avoid the false-negative (FN) and false-positive (FP) TB ...

2017
Valentín García-Gutiérrez María T Gómez-Casares José M Puerta Juan M Alonso-Domínguez Santiago Osorio Juan C Hernández-Boluda Rosa Collado María J Ramírez Fátima Ibáñez María L Martín Juan D Rodríguez-Gambarte Carolina Martínez-Laperche Montse Gómez Dolly V Fiallo Sara Redondo Alicia Rodríguez Concepción Ruiz-Nuño Juan L Steegmann Antonio Jiménez-Velasco

In chronic myeloid leukemia (CML) patients, 3-month BCR-ABL1 levels have consistently been correlated with further outcomes. Monitoring molecular responses in CML using the GeneXpert (Cepheid) platform has shown an optimal correlation with standardized RQ-PCR (IS) when measuring BCR-ABL1 levels lower than 10%, as it is not accurate for values over 10%. The aim of the present study was to determ...

2017
Peter M. Mbelele Said Aboud Stellah G. Mpagama Mecky I. Matee

BACKGROUND The introduction of Xpert MTB/RIF assay (Xpert) has significantly improved diagnosis of Tuberculosis (TB) in resource limited human immunodeficiency virus (HIV) endemic settings. We aimed to modify the Xpert protocol to improve the detection of Mycobacterium tuberculosis (MTB). METHODS This cross sectional study was conducted among presumptive pulmonary tuberculosis (PTB) patients ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید